Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer
Li Ding,
Daniel D. Billadeau
Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Glycogen Synthase Kinase 3
100%
Pancreatic Neoplasms
70%
Adenocarcinoma
38%
Phosphotransferases
12%
Therapeutics
12%
Protein-Serine-Threonine Kinases
9%
Expert Testimony
8%
Neoplasms
7%
Inborn Genetic Diseases
7%
Mitochondria
6%
Cytoplasm
6%
Cause of Death
6%
Survival Rate
6%
Proteins
6%
Cell Proliferation
5%
Neoplasm Metastasis
5%
Drug Therapy
4%
Growth
4%
Pharmaceutical Preparations
3%
Genes
3%
Chemical Compounds
Glycogen
88%
Glycogen Synthase Kinase 3 Inhibitor
16%
Oncogenic
12%
Threonine
10%
Serine
8%
Antineoplastic Agent
8%
Protein
7%
Chemical Transformation
5%
Resistance
5%